Deep Track Capital »

Alto Neuroscience shares owned by Deep Track Capital

Quarter-by-quarter ownership of Alto Neuroscience shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.2M 600k 15.35

More positions owned by Deep Track Capital

Springworks Therapeutics (SWTX)
Amgen (AMGN)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Dyne Therapeutics (DYN)
Alnylam Pharmaceuticals (ALNY)
Guardant Health (GH)
Argenx Se Sponsored Adr (ARGX)
Intra Cellular Therapies Put Option (ITCI)
Intellia Therapeutics (NTLA)
Ocular Therapeutix (OCUL)
Dynavax Technologies Corp Com New (DVAX)
Axsome Therapeutics (AXSM)
Geron Corporation (GERN)
Autolus Therapeutics Spon Ads (AUTL)

View all positions for Deep Track Capital

Top funds holding Alto Neuroscience

Falcon Edge Capital
FMR
RA Capital Management
Point72 Asset Management
72 Investment Holdings
T. Rowe Price Associates
Franklin Resources
ExodusPoint Capital Management
Deep Track Capital
Vanguard Group
Jennison Associates
Philadelphia Financial Management of San Francisco
Artal Group
Board of Trustees of The Leland Stanford Junior University
AWM Investment Company

View all funds holding Alto Neuroscience